| Product Code: ETC8837665 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The CKD market in the Philippines is sizable, driven by the rising burden of diabetes and hypertension. There is a growing focus on early intervention, lifestyle modifications, and the use of angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARBs) to slow disease progression.
The chronic kidney disease market in the Philippines is experiencing significant growth due to the increasing number of patients suffering from kidney failure. The demand for dialysis, renal transplantation, and related medical devices is rising, alongside innovations in kidney disease management. Additionally, public health campaigns are driving greater awareness and prevention.
Barriers include a rising patient burden, insufficient early screening, and limited dialysis capacity. Many patients are unaware of the condition until it reaches advanced stages, complicating management.
The chronic kidney disease (CKD) market in the Philippines presents a rapidly growing investment opportunity, driven by an aging population, urbanization, and rising incidences of diabetes and hypertension, which are major risk factors for CKD. The demand for diagnostic tools, medications, and dialysis equipment is expected to increase as more people require treatment. There are opportunities to invest in innovative dialysis machines, kidney function monitoring systems, and pharmaceuticals focused on CKD management. Additionally, expanding the availability of kidney transplants and specialized clinics will be key to addressing the healthcare needs of the growing CKD patient population in the Philippines.
The CKD market is prioritized in public health policy, with the DOH focusing on prevention, early detection, and management through national screening programs. The FDA oversees medication and device safety, while PhilHealth provides financial support for dialysis, transplant procedures, and maintenance medications.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Chronic Kidney Disease (CKD) Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Chronic Kidney Disease (CKD) Market - Industry Life Cycle |
3.4 Philippines Chronic Kidney Disease (CKD) Market - Porter's Five Forces |
3.5 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.8 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Chronic Kidney Disease (CKD) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic kidney disease in the Philippines |
4.2.2 Growing awareness about early detection and treatment of CKD |
4.2.3 Improving healthcare infrastructure and access to renal care services in the country |
4.3 Market Restraints |
4.3.1 High cost of chronic kidney disease treatment and management |
4.3.2 Limited availability of specialized healthcare professionals in the field of nephrology |
4.3.3 Lack of screening programs for early detection of CKD in the population |
5 Philippines Chronic Kidney Disease (CKD) Market Trends |
6 Philippines Chronic Kidney Disease (CKD) Market, By Types |
6.1 Philippines Chronic Kidney Disease (CKD) Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.4 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Treatment, 2021- 2031F |
6.2 Philippines Chronic Kidney Disease (CKD) Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Oral, 2021- 2031F |
6.2.3 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.4 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3 Philippines Chronic Kidney Disease (CKD) Market, By End Users |
6.3.1 Overview and Analysis |
6.3.2 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Homecare, 2021- 2031F |
6.3.5 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.3.6 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Philippines Chronic Kidney Disease (CKD) Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Philippines Chronic Kidney Disease (CKD) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 Philippines Chronic Kidney Disease (CKD) Market Import-Export Trade Statistics |
7.1 Philippines Chronic Kidney Disease (CKD) Market Export to Major Countries |
7.2 Philippines Chronic Kidney Disease (CKD) Market Imports from Major Countries |
8 Philippines Chronic Kidney Disease (CKD) Market Key Performance Indicators |
8.1 Average age of diagnosis for CKD patients in the Philippines |
8.2 Percentage of CKD patients undergoing regular screenings for early detection |
8.3 Adoption rate of telemedicine and remote monitoring solutions in CKD management |
8.4 Patient satisfaction scores with renal care services |
8.5 Rate of complications and hospital readmissions among CKD patients |
9 Philippines Chronic Kidney Disease (CKD) Market - Opportunity Assessment |
9.1 Philippines Chronic Kidney Disease (CKD) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Philippines Chronic Kidney Disease (CKD) Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Philippines Chronic Kidney Disease (CKD) Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.4 Philippines Chronic Kidney Disease (CKD) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Chronic Kidney Disease (CKD) Market - Competitive Landscape |
10.1 Philippines Chronic Kidney Disease (CKD) Market Revenue Share, By Companies, 2024 |
10.2 Philippines Chronic Kidney Disease (CKD) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |